SW – Smurfit WestRock plc

SW — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.57

Margin Of Safety %

Put/Call OI Ratio

0.28

EPS Next Q Diff

0.42

EPS Last/This Y

0.87

EPS This/Next Y

0.99

Price

37.51

Target Price

53.39

Analyst Recom

1.3

Performance Q

-27.31

Upside

-32.8%

Beta

0.95

Ticker: SW

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-16	SW	41.21	0.28	0.62	17337
2026-04-17	SW	42.24	0.26	0.04	17232
2026-04-20	SW	42.72	0.17	0.61	14748
2026-04-21	SW	41.24	0.19	0.14	15166
2026-04-22	SW	39.69	0.18	1.07	15237
2026-04-23	SW	40.52	0.20	0.03	15507
2026-04-24	SW	39.95	0.18	1.11	16616
2026-04-27	SW	40.04	0.19	0.93	16679
2026-04-28	SW	40.56	0.19	2.93	16469
2026-04-29	SW	39.66	0.27	0.17	17781
2026-04-30	SW	38.4	0.26	0.11	18965
2026-05-01	SW	39.43	0.22	0.16	22582
2026-05-04	SW	37.99	0.22	1.10	22456
2026-05-05	SW	39.53	0.23	0.41	22609
2026-05-06	SW	41.9	0.23	0.26	22689
2026-05-07	SW	41.62	0.24	0.36	22652
2026-05-08	SW	41.56	0.24	0.18	22591
2026-05-11	SW	40.92	0.24	1.36	22616
2026-05-12	SW	40.6	0.25	0.61	22818
2026-05-13	SW	40.44	0.25	20.95	22817
2026-05-14	SW	40.03	0.28	0.03	23344
2026-05-15	SW	37.51	0.28	1.98	23455
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-16	SW	41.21	-51.3	933.3	2.37
2026-04-17	SW	42.24	-51.3	983.2	2.37
2026-04-20	SW	42.72	-51.7	950.4	2.37
2026-04-21	SW	41.24	-51.7	859.1	2.37
2026-04-22	SW	39.69	-51.7	861.4	2.37
2026-04-23	SW	40.51	-51.7	948.9	2.37
2026-04-24	SW	39.95	-51.7	880.4	2.36
2026-04-27	SW	40.05	-51.7	901.5	2.36
2026-04-28	SW	40.55	-51.7	922.7	2.34
2026-04-29	SW	39.68	-51.7	865.1	2.34
2026-04-30	SW	38.39	-51.7	845.8	2.34
2026-05-01	SW	39.43	-51.7	886.6	2.34
2026-05-04	SW	37.98	7.7	835.4	2.34
2026-05-05	SW	39.53	-12.8	1264.7	2.25
2026-05-06	SW	41.90	-12.8	1295.1	2.25
2026-05-07	SW	41.62	-12.8	1181.8	2.23
2026-05-08	SW	41.56	-18.2	1194.8	2.21
2026-05-11	SW	40.92	-18.2	1166.6	2.21
2026-05-12	SW	40.59	-5.0	1186.8	2.21
2026-05-13	SW	40.44	-5.0	1195.4	2.21
2026-05-14	SW	40.05	-5.0	1175.3	2.21
2026-05-15	SW	37.51	-5.0	1088.7	2.21
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-17	SW	-2.36	-0.21	6.23
2026-04-20	SW	-2.36	-0.38	6.23
2026-04-21	SW	-2.36	-0.38	6.23
2026-04-22	SW	-2.36	-0.38	6.23
2026-04-23	SW	-2.36	-0.38	6.23
2026-04-24	SW	-2.36	-0.38	6.23
2026-04-27	SW	-2.23	-0.27	5.89
2026-04-28	SW	-2.23	-0.27	5.89
2026-04-29	SW	-2.23	-0.27	5.89
2026-04-30	SW	-2.23	-0.27	5.89
2026-05-01	SW	-2.23	-0.27	5.89
2026-05-04	SW	-2.23	-0.22	5.89
2026-05-05	SW	-2.23	-0.22	5.89
2026-05-06	SW	-2.23	-0.22	5.89
2026-05-07	SW	-2.23	-0.22	5.88
2026-05-08	SW	-2.23	-0.22	5.88
2026-05-11	SW	-2.23	0.07	5.88
2026-05-12	SW	-2.19	0.07	5.57
2026-05-13	SW	-2.19	0.07	5.57
2026-05-14	SW	-2.19	0.07	5.57
2026-05-15	SW	-2.19	0.07	5.57
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.33

Avg. EPS Est. Current Quarter

0.48

Avg. EPS Est. Next Quarter

0.75

Insider Transactions

-2.19

Institutional Transactions

0.07

Beta

0.95

Average Sales Estimate Current Quarter

7928

Average Sales Estimate Next Quarter

8254

Fair Value

52.97

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

37.6

Max Drawdown 5-Year %

-54.4

Target Price

53.39

P/E

52.23

Forward P/E

11.89

PEG

0.57

P/S

0.63

P/B

1.09

P/Free Cash Flow

18.49

EPS

0.72

Average EPS Est. Cur. Y

2.21

EPS Next Y. (Est.)

3.2

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1.22

Relative Volume

0.67

Return on Equity vs Sector %

-16.1

Return on Equity vs Industry %

-1

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.18

EBIT Estimation

1088.7

◆ SW Consumer Cyclical

$37.48

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

13/25

Volume

6/15

Valuation

18/20

TP/AR

2/10

Options

4/10

RSI

37.7

Range 1M

15.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

16/30

Estimates

4/20

Inst/Vol

2/15

Options

6/10

EPS Yr

15.5%

EPS NY

33.2%

52W%

25.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +120.3% upside

Quality

3/30

Valuation

25/30

Growth

11/25

Stability

5/10

LT Trend

4/5

Upside

+120.3%

Quality

MoS

41%

Smurfit WestRock plc

Sector: Consumer Cyclical

Industry: Packaging & Containers

Employees: 97000

Smurfit Westrock Plc, together with its subsidiaries, manufactures, distributes, and sells containerboard, corrugated containers, and other paper-based packaging products in North America, South America, Europe, Asia, Africa, Australia, and internationally. The company produces containerboard and paperboard; packaging of corrugated containers; consumer packaging; and offers solid board, kraft paper, and graphic board, as well as other packaging products, such as solidboard packaging, paper sacks and bag-in-box. It produces linerboard and corrugated medium and paperboard; and other paper-based packaging, such as folding cartons, inserts, labels and displays. The company primarily serves food and beverage, healthcare, beauty and personal care, garden, consumer goods, industrial, and foodservice markets. It markets its products through its own sales force, independent sales representatives, and independent distributors. Smurfit Westrock Plc was founded in 1934 and is headquartered in Dublin, Ireland.

Latest News

—

Caricamento notizie per SW…

stock quote shares SW – Smurfit WestRock plc Stock Price stock today

news today SW – Smurfit WestRock plc stock forecast ,stock prediction 2023 2024 2025

marketwatch SW – Smurfit WestRock plc yahoo finance google finance

stock history SW – Smurfit WestRock plc invest stock market

stock prices SW premarket after hours

ticker SW fair value insiders trading

MURA – Mural Oncology plc

MURA — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.66

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.04

Target Price

Analyst Recom

Performance Q

-1.45

Upside

N/A

Beta

2.88

Ticker: MURA

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-20	MURA	2.04	N/A	N/A	0
2026-04-23	MURA	2.04	N/A	N/A	0
2026-04-24	MURA	2.04	N/A	N/A	0
2026-04-27	MURA	2.04	N/A	N/A	0
2026-04-28	MURA	2.04	N/A	N/A	0
2026-04-29	MURA	2.04	N/A	N/A	0
2026-04-30	MURA	2.04	N/A	N/A	0
2026-05-01	MURA	2.04	N/A	N/A	0
2026-05-04	MURA	2.04	N/A	N/A	0
2026-05-05	MURA	2.04	N/A	N/A	0
2026-05-06	MURA	2.04	N/A	N/A	0
2026-05-07	MURA	2.04	N/A	N/A	0
2026-05-08	MURA	2.04	N/A	N/A	0
2026-05-11	MURA	2.04	N/A	N/A	0
2026-05-12	MURA	2.04	N/A	N/A	0
2026-05-13	MURA	2.04	N/A	N/A	0
2026-05-14	MURA	2.04	N/A	N/A	0
2026-05-15	MURA	2.04	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.37

Avg. EPS Est. Next Quarter

Insider Transactions

-2.62

Institutional Transactions

-16.45

Beta

2.88

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

0.64

P/Free Cash Flow

EPS

-6.93

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

-0.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-242.8

Return on Equity vs Industry %

-227.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

No data found for MURA

MURA

Latest News

—

Caricamento notizie per MURA…

stock quote shares MURA – Mural Oncology plc Stock Price stock today

news today MURA – Mural Oncology plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MURA – Mural Oncology plc yahoo finance google finance

stock history MURA – Mural Oncology plc invest stock market

stock prices MURA premarket after hours

ticker MURA fair value insiders trading

MDT – Medtronic Plc

MDT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.14

Margin Of Safety %

Put/Call OI Ratio

0.42

EPS Next Q Diff

0.02

EPS Last/This Y

0.04

EPS This/Next Y

0.52

Price

76.15

Target Price

107.62

Analyst Recom

1.85

Performance Q

-23.44

Upside

3.4%

Beta

0.62

Ticker: MDT

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-16	MDT	85.64	0.52	0.31	133410
2026-04-17	MDT	86.18	0.48	0.31	140540
2026-04-20	MDT	85.01	0.54	0.22	115171
2026-04-21	MDT	82	0.52	0.27	121033
2026-04-22	MDT	83.21	0.49	0.33	128703
2026-04-23	MDT	83.78	0.48	0.21	133601
2026-04-24	MDT	83.34	0.48	1.46	135463
2026-04-27	MDT	82.92	0.53	0.34	127408
2026-04-28	MDT	81.88	0.53	0.34	130617
2026-04-29	MDT	79.36	0.52	0.85	134832
2026-04-30	MDT	80.96	0.52	0.66	140910
2026-05-01	MDT	80	0.52	0.48	145373
2026-05-04	MDT	78.3	0.51	0.84	140958
2026-05-05	MDT	77.77	0.52	0.46	147980
2026-05-06	MDT	77.6	0.51	0.44	150458
2026-05-07	MDT	77.96	0.50	0.74	153226
2026-05-08	MDT	76.13	0.50	0.58	154400
2026-05-11	MDT	74.57	0.50	0.22	154567
2026-05-12	MDT	76.81	0.44	0.44	172537
2026-05-13	MDT	76.19	0.44	0.41	174488
2026-05-14	MDT	76.91	0.43	1.28	184710
2026-05-15	MDT	76.15	0.42	0.62	185618
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-16	MDT	85.65	-4.8	392.2	5.52
2026-04-17	MDT	86.18	-4.8	523.8	5.52
2026-04-20	MDT	85.00	-4.8	408.7	5.52
2026-04-21	MDT	81.99	-3.7	285.1	5.55
2026-04-22	MDT	83.21	-3.7	572.4	5.55
2026-04-23	MDT	83.79	-3.7	526.7	5.55
2026-04-24	MDT	83.34	-3.7	457.3	5.55
2026-04-27	MDT	82.92	-3.7	460.6	5.55
2026-04-28	MDT	81.89	-4.2	417.0	5.54
2026-04-30	MDT	80.96	-4.5	601.2	5.53
2026-05-01	MDT	80.00	-4.5	419.5	5.53
2026-05-04	MDT	78.29	-4.5	366.6	5.53
2026-05-05	MDT	77.76	-4.5	449.4	5.53
2026-05-06	MDT	77.58	-4.5	474.9	5.53
2026-05-07	MDT	77.94	-4.5	513.1	5.53
2026-05-08	MDT	76.12	-4.5	354.9	5.53
2026-05-11	MDT	74.53	-4.5	368.2	5.53
2026-05-12	MDT	76.82	-4.5	659.2	5.53
2026-05-13	MDT	76.19	-4.5	442.1	5.53
2026-05-14	MDT	76.98	-4.5	544.9	5.53
2026-05-15	MDT	76.15	-4.5	428.2	5.53
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-16	MDT	0	0.18	1.33
2026-04-17	MDT	0	0.18	1.33
2026-04-20	MDT	0	0.18	1.33
2026-04-21	MDT	0	0.18	1.33
2026-04-22	MDT	0	0.18	1.32
2026-04-23	MDT	-6.67	0.18	1.32
2026-04-24	MDT	-6.67	0.18	1.32
2026-04-27	MDT	-6.67	-0.20	1.20
2026-04-28	MDT	-6.67	-0.20	1.20
2026-04-29	MDT	-6.67	-0.20	1.20
2026-04-30	MDT	-6.67	-0.20	1.20
2026-05-01	MDT	-6.67	-0.20	1.20
2026-05-04	MDT	-6.67	0.09	1.20
2026-05-05	MDT	-6.67	0.09	1.20
2026-05-06	MDT	-6.67	0.09	1.20
2026-05-07	MDT	-6.67	0.09	1.20
2026-05-08	MDT	-6.67	0.09	1.20
2026-05-11	MDT	-6.67	0.16	1.20
2026-05-12	MDT	-6.67	0.16	1.14
2026-05-13	MDT	-6.67	0.16	1.14
2026-05-14	MDT	-6.67	0.16	1.14
2026-05-15	MDT	-6.67	0.16	1.14
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

1.36

Avg. EPS Est. Current Quarter

1.55

Avg. EPS Est. Next Quarter

1.38

Insider Transactions

-6.67

Institutional Transactions

0.16

Beta

0.62

Average Sales Estimate Current Quarter

9622

Average Sales Estimate Next Quarter

9337

Fair Value

106.8

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-45.1

Target Price

107.62

P/E

21.26

Forward P/E

12.58

PEG

2.15

P/S

2.76

P/B

P/Free Cash Flow

18.08

EPS

3.58

Average EPS Est. Cur. Y

5.53

EPS Next Y. (Est.)

6.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.02

Return on Equity vs Sector %

-17.5

Return on Equity vs Industry %

-2.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

428.2

◆ MDT Healthcare

$76.17

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

15/25

Volume

4/15

Valuation

20/20

TP/AR

1/10

Options

5/10

RSI

33.8

Range 1M

14%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

9/30

Estimates

6/20

Inst/Vol

3/15

Options

5/10

EPS Yr

0.5%

EPS NY

9.8%

52W%

5.8%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +57.8% upside

Quality

10/30

Valuation

22/30

Growth

6/25

Stability

7/10

LT Trend

3/5

Upside

+57.8%

Quality

MoS

40%

Medtronic plc.

Sector: Healthcare

Industry: Medical Devices

Employees: 95000

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

MDT

Latest News

—

Caricamento notizie per MDT…

stock quote shares MDT – Medtronic Plc Stock Price stock today

news today MDT – Medtronic Plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MDT – Medtronic Plc yahoo finance google finance

stock history MDT – Medtronic Plc invest stock market

stock prices MDT premarket after hours

ticker MDT fair value insiders trading

ITRM – Iterum Therapeutics Plc

ITRM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.85

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.1

EPS Last/This Y

EPS This/Next Y

0.35

Price

0.03

Target Price

Analyst Recom

Performance Q

-91.64

Upside

N/A

Beta

3.42

Ticker: ITRM

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-20	ITRM	0.03	N/A	N/A	0
2026-04-23	ITRM	0.03	N/A	N/A	0
2026-04-24	ITRM	0.03	N/A	N/A	0
2026-04-27	ITRM	0.03	N/A	N/A	0
2026-04-28	ITRM	0.03	N/A	N/A	0
2026-04-29	ITRM	0.03	N/A	N/A	0
2026-04-30	ITRM	0.03	N/A	N/A	0
2026-05-01	ITRM	0.03	N/A	N/A	0
2026-05-04	ITRM	0.03	N/A	N/A	0
2026-05-05	ITRM	0.03	N/A	N/A	0
2026-05-06	ITRM	0.03	N/A	N/A	0
2026-05-07	ITRM	0.03	N/A	N/A	0
2026-05-08	ITRM	0.03	N/A	N/A	0
2026-05-11	ITRM	0.03	N/A	N/A	0
2026-05-12	ITRM	0.03	N/A	N/A	0
2026-05-13	ITRM	0.03	N/A	N/A	0
2026-05-14	ITRM	0.03	N/A	N/A	0
2026-05-15	ITRM	0.03	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

Last Quarter Act. EPS

-0.2

Avg. EPS Est. Current Quarter

-0.14

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

1.46

Institutional Transactions

Beta

3.42

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.9

Max Drawdown 5-Year %

-99.9

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-0.72

Average EPS Est. Cur. Y

-0.66

EPS Next Y. (Est.)

-0.31

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

337.7

Return on Equity vs Industry %

354.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.33

EBIT Estimation

9.2

No data found for ITRM

Iterum Therapeutics plc

Sector: Healthcare

Industry: Biotechnology

Employees: 9

Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel anti-infective compound with oral and intravenous formulations to treat uncomplicated urinatry tract infections, complicated urinary tract infections, and complicated intra-abdominal infections, as well as community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory diseases. Iterum Therapeutics plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

ITRM

Latest News

—

Caricamento notizie per ITRM…

stock quote shares ITRM – Iterum Therapeutics Plc Stock Price stock today

news today ITRM – Iterum Therapeutics Plc stock forecast ,stock prediction 2023 2024 2025

marketwatch ITRM – Iterum Therapeutics Plc yahoo finance google finance

stock history ITRM – Iterum Therapeutics Plc invest stock market

stock prices ITRM premarket after hours

ticker ITRM fair value insiders trading

AMRN – Amarin Corp ADR

AMRN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

3.23

Margin Of Safety %

-24

Put/Call OI Ratio

0.17

EPS Next Q Diff

0.19

EPS Last/This Y

1.79

EPS This/Next Y

0.99

Price

14.47

Target Price

12.5

Analyst Recom

Performance Q

-1.22

Upside

-489.4%

Beta

0.83

Ticker: AMRN

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-20	AMRN	14.51	0.15	0.07	2061
2026-04-23	AMRN	14.77	0.13	0.07	2404
2026-04-24	AMRN	14.35	0.13	0.03	2428
2026-04-27	AMRN	13.93	0.13	0.44	2473
2026-04-28	AMRN	13.9001	0.14	0.13	2577
2026-04-29	AMRN	14.24	0.14	0.20	2801
2026-04-30	AMRN	13.88	0.15	0.21	2847
2026-05-01	AMRN	13.99	0.15	0.41	2908
2026-05-04	AMRN	14.2	0.16	0.02	2963
2026-05-05	AMRN	14.52	0.16	0.03	2976
2026-05-06	AMRN	14.95	0.16	0.35	3014
2026-05-07	AMRN	14.78	0.16	0.40	3062
2026-05-08	AMRN	15.05	0.16	1.11	3080
2026-05-11	AMRN	14.94	0.16	0.06	3116
2026-05-12	AMRN	14.95	0.17	0.00	3115
2026-05-13	AMRN	15.05	0.17	0.13	3116
2026-05-14	AMRN	14.77	0.17	0.04	3153
2026-05-15	AMRN	14.5	0.17	2.40	3215
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-16	AMRN	14.65	142.5	-	0.78
2026-04-17	AMRN	14.97	142.5	-	0.78
2026-04-20	AMRN	14.57	142.5	-	0.78
2026-04-21	AMRN	14.59	142.5	-	0.78
2026-04-22	AMRN	14.49	142.5	-	0.78
2026-04-23	AMRN	14.73	142.5	-	0.78
2026-04-24	AMRN	14.34	142.5	-	0.78
2026-04-27	AMRN	13.93	142.5	-	0.78
2026-04-28	AMRN	13.95	142.5	-	0.78
2026-04-30	AMRN	13.86	142.5	-	0.78
2026-05-01	AMRN	13.97	142.5	-	0.78
2026-05-04	AMRN	14.22	-80.5	-	0.78
2026-05-05	AMRN	14.45	-80.5	-	0.78
2026-05-06	AMRN	14.90	-80.5	-	0.78
2026-05-07	AMRN	14.82	-80.5	-	0.78
2026-05-08	AMRN	15.00	-80.5	-	-0.01
2026-05-11	AMRN	14.94	-111.5	-	-0.01
2026-05-12	AMRN	14.95	-111.5	-	-0.01
2026-05-13	AMRN	15.11	-111.5	-	-0.01
2026-05-14	AMRN	14.72	-111.5	-	-0.01
2026-05-15	AMRN	14.47	-111.5	-	-0.01
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-16	AMRN	0.00	-0.02	2.20
2026-04-17	AMRN	0.00	-0.02	2.20
2026-04-20	AMRN	0.00	-0.02	2.20
2026-04-21	AMRN	0.00	-0.02	2.20
2026-04-22	AMRN	0.00	-0.02	2.20
2026-04-23	AMRN	0.00	-0.02	2.20
2026-04-24	AMRN	0.00	-0.02	2.20
2026-04-27	AMRN	0.00	-0.01	2.06
2026-04-28	AMRN	0.00	-0.01	2.06
2026-04-29	AMRN	0.00	-0.01	2.06
2026-04-30	AMRN	0.00	-0.01	2.06
2026-05-01	AMRN	0.00	-0.01	2.06
2026-05-04	AMRN	0.00	-0.01	0
2026-05-05	AMRN	0.00	-0.01	2.04
2026-05-06	AMRN	0.00	-0.01	2.04
2026-05-07	AMRN	0.00	-0.01	2.04
2026-05-08	AMRN	0.00	-0.01	2.04
2026-05-11	AMRN	0.00	0.02	2.04
2026-05-12	AMRN	0.00	0.02	3.23
2026-05-13	AMRN	0.00	0.02	3.23
2026-05-14	AMRN	0.00	0.02	3.23
2026-05-15	AMRN	0.00	0.02	3.23
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.2

Avg. EPS Est. Current Quarter

-0.1

Avg. EPS Est. Next Quarter

-0.01

Insider Transactions

Institutional Transactions

0.02

Beta

0.83

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

10.98

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

87.9

Max Drawdown 5-Year %

-93.1

Target Price

12.5

P/E

Forward P/E

264.73

PEG

P/S

1.41

P/B

0.68

P/Free Cash Flow

EPS

-1.62

Average EPS Est. Cur. Y

-0.01

EPS Next Y. (Est.)

0.98

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-15.52

Relative Volume

0.75

Return on Equity vs Sector %

-34.4

Return on Equity vs Industry %

-44.5

EPS 1 7Days Diff

-0.8

EPS 1 30Days Diff

-0.79

EBIT Estimation

◆ AMRN Healthcare

$14.56

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

10/20

Pullback

9/25

Volume

9/15

Valuation

9/20

TP/AR

0/10

Options

6/10

RSI

48.3

Range 1M

59.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

23/30

Estimates

2/20

Inst/Vol

3/15

Options

7/10

EPS Yr

61.1%

EPS NY

257.1%

52W%

39.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +57.6% upside

Quality

5/30

Valuation

15/30

Growth

19/25

Stability

7/10

LT Trend

4/5

Upside

+57.6%

Quality

MoS

-24%

Amarin Corporation plc

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 80

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

AMRN

Latest News

—

Caricamento notizie per AMRN…

stock quote shares AMRN – Amarin Corp ADR Stock Price stock today

news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch AMRN – Amarin Corp ADR yahoo finance google finance

stock history AMRN – Amarin Corp ADR invest stock market

stock prices AMRN premarket after hours

ticker AMRN fair value insiders trading

ALKS – Alkermes plc

ALKS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

12.08

Margin Of Safety %

-25

Put/Call OI Ratio

0.91

EPS Next Q Diff

0.76

EPS Last/This Y

-0.04

EPS This/Next Y

0.92

Price

37.47

Target Price

45.44

Analyst Recom

1.44

Performance Q

13.03

Upside

-16.0%

Beta

0.34

Ticker: ALKS

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-20	ALKS	34.22	1.54	0.08	6442
2026-04-23	ALKS	33.92	1.45	0.82	6712
2026-04-24	ALKS	33.3	1.44	0.20	6769
2026-04-27	ALKS	33.7	1.43	0.08	6806
2026-04-28	ALKS	34.1	1.20	0.13	7360
2026-04-29	ALKS	33.72	1.16	0.59	7543
2026-04-30	ALKS	33.7	1.15	1.80	7660
2026-05-01	ALKS	33.37	1.15	6.00	7708
2026-05-04	ALKS	34.14	1.17	1.41	7762
2026-05-05	ALKS	36.26	1.20	0.34	7765
2026-05-06	ALKS	35.31	1.06	0.09	8660
2026-05-07	ALKS	35.4	1.06	0.08	8708
2026-05-08	ALKS	35	1.04	0.20	8814
2026-05-11	ALKS	35.48	1.04	0.14	8822
2026-05-12	ALKS	38.3	1.05	0.37	8790
2026-05-13	ALKS	38.93	0.76	0.28	12345
2026-05-14	ALKS	38.38	0.79	0.98	13165
2026-05-15	ALKS	37.47	0.91	0.02	13593
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-16	ALKS	33.76	-26.9	160.8	2.35
2026-04-17	ALKS	34.51	-26.9	172.2	2.35
2026-04-20	ALKS	34.21	-26.9	167.6	2.35
2026-04-21	ALKS	33.51	-113.7	156.9	0.06
2026-04-22	ALKS	33.75	-113.7	160.6	0.06
2026-04-23	ALKS	33.91	-113.7	163.1	0.06
2026-04-24	ALKS	33.30	-113.7	153.8	0.06
2026-04-27	ALKS	33.73	-113.7	160.3	0.06
2026-04-28	ALKS	34.15	-113.7	166.6	0.06
2026-04-30	ALKS	33.72	-113.7	160.2	0.06
2026-05-01	ALKS	33.38	-113.7	154.9	0.06
2026-05-04	ALKS	34.15	-113.7	166.7	0.06
2026-05-05	ALKS	36.26	-113.7	198.6	0.06
2026-05-06	ALKS	35.30	-113.7	153.3	0.06
2026-05-07	ALKS	35.40	-92.6	-	0.06
2026-05-08	ALKS	35.00	-92.6	-	0.06
2026-05-11	ALKS	35.48	-	-	-0.56
2026-05-12	ALKS	38.30	-72.7	-	0.98
2026-05-13	ALKS	38.91	-51.6	-	0.98
2026-05-14	ALKS	38.36	-51.6	-	1.43
2026-05-15	ALKS	37.47	-51.6	-	1.43
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-16	ALKS	-3.81	3.29	11.67
2026-04-17	ALKS	-3.81	3.29	11.67
2026-04-20	ALKS	-3.81	3.27	11.67
2026-04-21	ALKS	-3.81	3.27	11.67
2026-04-22	ALKS	-3.81	3.27	11.65
2026-04-23	ALKS	-4.16	3.27	11.65
2026-04-24	ALKS	-4.16	3.27	11.65
2026-04-27	ALKS	-4.16	2.60	12.06
2026-04-28	ALKS	-4.16	2.60	12.06
2026-04-29	ALKS	-4.16	2.60	12.06
2026-04-30	ALKS	-4.16	2.60	12.06
2026-05-01	ALKS	-4.16	2.60	12.06
2026-05-04	ALKS	-4.16	2.19	12.06
2026-05-05	ALKS	-4.23	2.19	12.06
2026-05-06	ALKS	-4.23	2.19	12.06
2026-05-07	ALKS	-4.23	2.19	12.06
2026-05-08	ALKS	-4.22	2.19	12.03
2026-05-11	ALKS	-4.24	2.31	12.03
2026-05-12	ALKS	-4.22	2.31	12.08
2026-05-13	ALKS	-4.22	2.31	12.08
2026-05-14	ALKS	-4.22	2.31	12.08
2026-05-15	ALKS	-4.22	2.31	12.08
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.4

Avg. EPS Est. Current Quarter

0.33

Avg. EPS Est. Next Quarter

0.36

Insider Transactions

-4.22

Institutional Transactions

2.31

Beta

0.34

Average Sales Estimate Current Quarter

458

Average Sales Estimate Next Quarter

473

Fair Value

28.23

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

5.3

Max Drawdown 5-Year %

-33.2

Target Price

45.44

P/E

41.67

Forward P/E

60.01

PEG

P/S

P/B

3.56

P/Free Cash Flow

28.17

EPS

0.9

Average EPS Est. Cur. Y

1.43

EPS Next Y. (Est.)

2.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.78

Relative Volume

0.55

Return on Equity vs Sector %

-18.2

Return on Equity vs Industry %

0.7

EPS 1 7Days Diff

1.4

EPS 1 30Days Diff

1.37

EBIT Estimation

◆ ALKS Healthcare

$37.48

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

2/25

Volume

8/15

Valuation

11/20

TP/AR

5/10

Options

5/10

RSI

62.7

Range 1M

71.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

17/30

Estimates

10/20

Inst/Vol

7/15

Options

5/10

EPS Yr

-117%

EPS NY

356.5%

52W%

86.5%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +56.6% upside

Quality

8/30

Valuation

13/30

Growth

14/25

Stability

6/10

LT Trend

1/5

Upside

+56.6%

Quality

MoS

-25%

Alkermes plc

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 2050

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

ALKS

Latest News

—

Caricamento notizie per ALKS…

stock quote shares ALKS – Alkermes plc Stock Price stock today

news today ALKS – Alkermes plc stock forecast ,stock prediction 2023 2024 2025

marketwatch ALKS – Alkermes plc yahoo finance google finance

stock history ALKS – Alkermes plc invest stock market

stock prices ALKS premarket after hours

ticker ALKS fair value insiders trading

No more stocks to show

SW – Smurfit WestRock plc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SW

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

MURA – Mural Oncology plc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MURA

No data found

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y